
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $101K | $101K | $212K | $152K | $146K | |
Revenue Growth (YoY) | 3.06% | -- | 109.9% | -28.3% | -3.95% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $396K | $360K | $317K | $338K | $335K | |
Other Inc / (Exp) | $85K | $191K | $131K | -- | $6K | |
Operating Expenses | $468K | $437K | $374K | $395K | $383K | |
Operating Income | -$367K | -$336K | -$162K | -$243K | -$237K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$36K | $70K | $181K | -$21K | -$18K | |
Earnings of Discontinued Ops. | $2M | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $1.9M | $70K | $181K | -$21K | -$18K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.9M | $70K | $181K | -$21K | -$18K | |
Basic EPS (Cont. Ops) | $0.37 | $0.01 | $0.04 | -$0.01 | -$0.01 | |
Diluted EPS (Cont. Ops) | $0.37 | $0.01 | $0.04 | -$0.01 | -$0.01 | |
Weighted Average Basic Share | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | |
Weighted Average Diluted Share | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | |
EBITDA | -$12K | $88K | $193K | -$230K | -$224K | |
EBIT | -$24K | $75K | $181K | -$243K | -$237K | |
Revenue (Reported) | $101K | $101K | $212K | $152K | $146K | |
Operating Income (Reported) | -$367K | -$336K | -$162K | -$243K | -$237K | |
Operating Income (Adjusted) | -$24K | $75K | $181K | -$243K | -$237K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $26K | $45K | $45K | $36K | $38K | |
Revenue Growth (YoY) | -- | 73.08% | -- | -20% | 5.56% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $74K | $80K | $68K | $78K | $89K | |
Other Inc / (Exp) | $91K | -- | -- | -- | -- | |
Operating Expenses | $92K | $92K | $80K | $91K | $101K | |
Operating Income | -$66K | -$47K | -$35K | -$55K | -$63K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $79K | $5K | $17K | $2K | -$20K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $79K | $5K | $17K | $2K | -$20K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $79K | $5K | $17K | $2K | -$20K | |
Basic EPS (Cont. Ops) | $0.01 | $0.01 | $0.01 | $0.01 | -$0.01 | |
Diluted EPS (Cont. Ops) | $0.01 | $0.01 | $0.01 | $0.01 | -$0.01 | |
Weighted Average Basic Share | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | |
Weighted Average Diluted Share | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | |
EBITDA | $84K | -$44K | -$32K | -$52K | -$60K | |
EBIT | $81K | -$47K | -$35K | -$55K | -$63K | |
Revenue (Reported) | $26K | $45K | $45K | $36K | $38K | |
Operating Income (Reported) | -$66K | -$47K | -$35K | -$55K | -$63K | |
Operating Income (Adjusted) | $81K | -$47K | -$35K | -$55K | -$63K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $102K | $121K | $212K | $143K | $148K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $366K | $366K | $305K | $348K | $346K | |
Other Inc / (Exp) | $176K | $100K | $131K | -- | -- | |
Operating Expenses | $441K | $438K | $362K | $406K | $393K | |
Operating Income | -$339K | -$317K | -$150K | -$263K | -$245K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $76K | -$4K | $193K | -$36K | -$40K | |
Earnings of Discontinued Ops. | $2M | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $2.1M | -$4K | $193K | -$36K | -$40K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $2.1M | -$4K | $193K | -$36K | -$40K | |
Basic EPS (Cont. Ops) | $0.40 | -- | $0.05 | -$0.03 | -$0.03 | |
Diluted EPS (Cont. Ops) | $0.40 | -- | $0.05 | -$0.03 | -$0.03 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $100K | -$26K | $205K | -$250K | -$232K | |
EBIT | $87K | -$53K | $193K | -$263K | -$245K | |
Revenue (Reported) | $102K | $121K | $212K | $143K | $148K | |
Operating Income (Reported) | -$339K | -$317K | -$150K | -$263K | -$245K | |
Operating Income (Adjusted) | $87K | -$53K | $193K | -$263K | -$245K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $26K | $45K | $45K | $36K | $38K | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $74K | $80K | $68K | $78K | $89K | |
Other Inc / (Exp) | $91K | -- | -- | -- | -- | |
Operating Expenses | $92K | $92K | $80K | $91K | $101K | |
Operating Income | -$66K | -$47K | -$35K | -$55K | -$63K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $79K | $5K | $17K | $2K | -$20K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $79K | $5K | $17K | $2K | -$20K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $79K | $5K | $17K | $2K | -$20K | |
Basic EPS (Cont. Ops) | $0.01 | $0.01 | $0.01 | $0.01 | -$0.01 | |
Diluted EPS (Cont. Ops) | $0.01 | $0.01 | $0.01 | $0.01 | -$0.01 | |
Weighted Average Basic Share | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | |
Weighted Average Diluted Share | $5.1M | $5.1M | $5.1M | $5.1M | $5.1M | |
EBITDA | $84K | -$44K | -$32K | -$52K | -$60K | |
EBIT | $81K | -$47K | -$35K | -$55K | -$63K | |
Revenue (Reported) | $26K | $45K | $45K | $36K | $38K | |
Operating Income (Reported) | -$66K | -$47K | -$35K | -$55K | -$63K | |
Operating Income (Adjusted) | $81K | -$47K | -$35K | -$55K | -$63K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $27K | $252K | $436K | $447K | $363K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $92K | -- | $30K | $12K | $9K | |
Total Current Assets | $3.8M | $3.8M | $466K | $459K | $372K | |
Property Plant And Equipment | $656K | $643K | $631K | $629K | $636K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $4.6M | $4.5M | $4.6M | $4.6M | $4.6M | |
Accounts Payable | $80K | $28K | $23K | $36K | $20K | |
Accrued Expenses | $32K | $32K | $40K | $39K | $37K | |
Current Portion Of Long-Term Debt | $52K | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $164K | $60K | $63K | $75K | $57K | |
Long-Term Debt | $122K | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $286K | $60K | $63K | $75K | $57K | |
Common Stock | $52K | $52K | $52K | $52K | $52K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $4.3M | $4.4M | $4.6M | $4.6M | $4.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $4.3M | $4.4M | $4.6M | $4.6M | $4.5M | |
Total Liabilities and Equity | $4.6M | $4.5M | $4.6M | $4.6M | $4.6M | |
Cash and Short Terms | $27K | $252K | $436K | $447K | $363K | |
Total Debt | $174K | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $43K | $254K | $437K | $395K | $333K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $22K | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $220K | $38K | $62K | $61K | $57K | |
Total Current Assets | $3.9M | $3.9M | $4M | $456K | $390K | |
Property Plant And Equipment | $653K | $640K | $628K | $626K | $633K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $4.7M | $4.5M | $4.7M | $4.6M | $4.6M | |
Accounts Payable | $108K | $74K | $55K | $25K | $20K | |
Accrued Expenses | $18K | $22K | $21K | $42K | $28K | |
Current Portion Of Long-Term Debt | $52K | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $178K | $96K | $76K | $67K | $48K | |
Long-Term Debt | $115K | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $293K | $96K | $76K | $67K | $48K | |
Common Stock | $52K | $52K | $52K | $52K | $52K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $4.4M | $4.4M | $4.6M | $4.6M | $4.5M | |
Total Liabilities and Equity | $4.7M | $4.5M | $4.7M | $4.6M | $4.6M | |
Cash and Short Terms | $43K | $254K | $437K | $395K | $333K | |
Total Debt | $167K | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.9M | $70K | $181K | -$21K | -$18K | |
Depreciation & Amoritzation | $12K | $13K | $12K | $13K | $13K | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$535K | $123K | $184K | $22K | -$64K | |
Capital Expenditures | -- | -- | -- | $11K | $20K | |
Cash Acquisitions | $85K | -- | -- | -- | -- | |
Cash From Investing | $593K | $276K | -- | -$11K | -$20K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$53K | -$174K | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$53K | -$174K | -- | -- | -- | |
Beginning Cash (CF) | $22K | $27K | $252K | $436K | $447K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $5K | $225K | $184K | $11K | -$84K | |
Ending Cash (CF) | $27K | $252K | $436K | $447K | $363K | |
Levered Free Cash Flow | -$535K | $123K | $184K | $11K | -$84K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $79K | $5K | $17K | $2K | -$20K | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $47K | $18K | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $25K | $2K | $1K | -$52K | -$30K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$9K | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$9K | -- | -- | -- | -- | |
Beginning Cash (CF) | $27K | $252K | $436K | $447K | $363K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $16K | $2K | $1K | -$52K | -$30K | |
Ending Cash (CF) | $43K | $254K | $437K | $395K | $333K | |
Levered Free Cash Flow | $25K | $2K | $1K | -$52K | -$30K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.1M | -$4K | $193K | -$36K | -$40K | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$493K | $100K | $183K | -$31K | -$42K | |
Capital Expenditures | -- | -- | -- | $11K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$50K | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$50K | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $50K | $211K | $183K | -$42K | -$62K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$493K | $100K | $183K | -$31K | -$42K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $79K | $5K | $17K | $2K | -$20K | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $47K | $18K | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $25K | $2K | $1K | -$52K | -$30K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$9K | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$9K | -- | -- | -- | -- | |
Beginning Cash (CF) | $27K | $252K | $436K | $447K | $363K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $16K | $2K | $1K | -$52K | -$30K | |
Ending Cash (CF) | $43K | $254K | $437K | $395K | $333K | |
Levered Free Cash Flow | $25K | $2K | $1K | -$52K | -$30K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.